New dermal filler launched

August 6, 2008

San Diego - Artes Medical announces the immediate launch and commercial sale of Food and Drug Administration-approved Elevess, a new hyaluronic acid dermal filler formulated with an anesthetic for patient comfort, according to a press release.

San Diego

- Artes Medical announces the immediate launch and commercial sale of Food and Drug Administration-approved Elevess, a new hyaluronic acid dermal filler formulated with an anesthetic for patient comfort, according to a press release.

Elevess is a safe, effective and less expensive alternative for the treatment of facial wrinkles, particularly nasolabial folds. In a radomized, controlled pivotal study of 208 patients, Elevess was shown to be safe and effective for up to six months, according to the company.